American life expectancy is now at its lowest in nearly two

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28 Shady #104471
228
American life expectancy is now at its lowest in nearly two decades

https://www.npr.org/sections/health-shots/202...wo-decades

They left a word out, should be from Covid vaccines, not Covid? They did not add that deaths from the Flu were way down in the same time span? Flu cases were reported way down during COVID from these same sources?

>>>>>>>>

The average life expectancy for Americans shortened by over seven months last year, according to new data from the Centers for Disease Control and Prevention.

That decrease follows an already big decline of 1.8 years in 2020. As a result, the expected life span of someone born in the U.S. is now 76.4 years — the shortest it has been in nearly two decades.

The two reports, released by the CDC on Thursday, show deaths from COVID-19 and drug overdoses, most notably synthetic opioids like fentanyl, were the primary drivers of the drop in life expectancy.

"It's not a good year for the data, let's put it that way," says CDC statistician Kenneth Kochanek.

It's rare to see such big changes in life span year to year, but the pandemic claimed nearly 417,000 lives last year — more than even the year before — making COVID-19 the third leading cause of death for the second consecutive year.

Kochanek and his colleagues had hoped the release of new vaccines might make for a healthier 2021, and didn't anticipate deaths from COVID-19 would top the prior year. But they were wrong. In fact, COVID-19 accounted for about 60% of the decline in life expectancy.

Preliminary data from 2022 so far indicate deaths from COVID-19 are on the decline, but Kochanek says that doesn't mean life expectancy will rebound quickly in years to come, because COVID-19 was, by no means, the only contributor to the higher death toll in 2021.

Heart disease, the leading cause of death in the U.S., along with other top killers like cancer, diabetes and kidney disease also proved more lethal in 2021.

Meanwhile, deaths from Alzheimer's, flu and pneumonia declined, perhaps because the coronavirus hit the elderly population particularly hard.

The new numbers also speak to the acute mental health crisis that's run parallel to the pandemic: Deaths from drug overdoses reached over 106,000 last year — another major factor reducing life expectancy, according to the second CDC analysis released on Thursday.

Deaths by suicide and from liver disease, or cirrhosis, caused by alcohol also increased — shortening the average American life span.

"The majority of those deaths are to younger people, and deaths to younger people affect the overall life expectancy more than deaths to the elderly," Kochanek says.

Men and women saw a similar decline in life expectancy last year, but women are living, on average, until over 79 years old, which is about six years longer than men

The CDC also found that death rates for certain racial and ethnic groups actually decreased last year, specifically among Hispanic and Black men. Death rates increased for almost all other groups, although it was most pronounced among white men and women, as well as American Indian or Alaska Native women.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

HSBC Boosts Tender Offer: Capital Management Maneuver

Updated Category News Views 56

HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...

Continue Reading
SAS: A Leader in AML Transaction Monitoring Tech

Updated Category News Views 90

The Evolving Landscape of AML Solutions Banks are drowning in a sea of alerts these days, making it tough to sift through and identify real threats. In this wild scenario, SAS has snagged the spotlight, with Chartis Research tipping its hat to them again. Their Anti-Money Laundering (AML) technology is planted right at the cutting edge of this rapidly changing landscape....

Continue Reading
Aries Ignites a Social Renaissance in La Jolla

Updated Category News Views 83

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

Continue Reading
iQIYI's AI Resurrects 90-Year-Old Lost Film

Updated Category News Views 24

A Nod to the Past with Tech of Tomorrow Diving into the nitty-gritty of iQIYI's latest cinematic triumph, there's a world where film meets futuristic AI, turning a motley crew of photos and clippings into a full-fledged movie. It's sorcery, if you ask me. "Visiting Shanghai after Sixty Years", vanished for nearly 90 years, has been crafted into existence again by...

Continue Reading
AutoFull Drops C3 Pro—Gaming Chairs With Flair

Updated Category News Views 63

AutoFull Gambles on Flair and Comfort AutoFull is shaking things up with the C3 Pro Series, blending striking aesthetics and tech-focused comfort features aimed right at gamers' sweet spots. Launching ahead of the Black Friday buzz, these new models promise to add some serious pizzazz to your gaming setup, whether it's the Advanced model's extra features or the more basic...

Continue Reading
Major Donations Boost Mesothelioma Research Funding

Updated Category News Views 104

Significant Boosts in Mesothelioma Support November's chill didn't slow down major support for mesothelioma initiatives. On October 22, 2026, during the grand setting of the Foundation's 2026 International Symposium on Malignant Mesothelioma in The Woodlands, Texas, MesoCare.org and Danziger & De Llano, LLP stepped up big time. Their philanthropic moves weren't just about...

Continue Reading
Kuaishou Prepares for Q3 Financial Reveals—November 19

Updated Category News Views 53

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 44

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading
Custom Antibody Market Eyes $1.13B by 2031 Growth

Updated Category News Views 152

Examining the Custom Antibody Market's Growth Projections The custom antibody market's been reeling in some serious attention lately. With the muscle to hit $1.13 billion by the end of 2031, this market's not slouching around. We're talking about a 9.5% compound annual growth rate here, folks. Now that's a figure that gives you something to chew over your coffee. What...

Continue Reading
Alley Cat Allies Sues Lincolnton Over Cat Shooting

Updated Category News Views 9

Legal Battle Over a Cat's Tragic End Picture the scene: a peaceful neighborhood in Lincolnton, Georgia, where the serenity was ripped apart by the shocking shooting of Piper the cat. This isn't some playground scuffle, my friends. Alley Cat Allies has taken this tragedy to the courts, filing a lawsuit against the city and its mayor. What's at stake here isn't just legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Research Frontiers Reports Significant Revenue Growth in Q1

Updated Category News Views 246

Research Frontiers Reports Strong Financial Results for Q1 WOODBURY, N.Y. — Research Frontiers Inc. (NASDAQ: REFR) has released its financial results for the first quarter of 2025, demonstrating robust growth in revenue. The management team will engage with stakeholders during a conference call set for later today to discuss these outcomes and share insights on recent...

Continue Reading
Gentoo Media Shares Boosted by Recent Acquisition News

Updated Category News Views 103

Gentoo Media's Share Acquisition Update Today, news emerged about a significant share acquisition involving Gentoo Media Inc., a prominent player in the online gambling and sports betting industry. MJ Foundation Fundacja Rodzinna, associated with Mateusz Juroszek, a board member of Gentoo Media, has successfully acquired 27,000 shares at an average price of SEK 20.98 per...

Continue Reading
XTIA Experiences Major Stock Collapse, Hits Unprecedented Low

Updated Category News Views 925

XTIA Stock Experiences Significant Downturn In recent market developments, XTIA stock has fallen to an alarming price of $0.08, marking a troubling 52-week low. This dramatic drop is a clear indication of the challenges the company has faced over the past year, with a staggering decline of around -99.01%. Investors are increasingly worried as the stock struggles to...

Continue Reading
Samsung and Apple's Rivalry: The Foldable Phone Showdown

Updated Category News Views 238

Samsung's Bold Move in the Foldable Market Samsung Electronics Co., Ltd (OTC: SSNLF) has made a significant impact in the smartphone industry with the release of its latest innovation. The Galaxy Z TriFold, a revolutionary device designed to fold twice and transform into a 10-inch display, is a game changer in the realm of foldable phones. This new model showcases...

Continue Reading
Investigation into MoonLake Immunotherapeutics Sparks Concern

Updated Category News Views 305

Investigation Into MoonLake Immunotherapeutics MoonLake Immunotherapeutics, a clinical stage biotechnology company, is making headlines due to an investigation initiated by a leading securities law firm. Investors are understandably worried after the company's stock price plummeted significantly following disappointing results from a critical drug trial. The VELA Trials...

Continue Reading